Award recordCONTRACT

PROGENICS PHARMACEUTICALS INC

PIID 36C24123F0104· VHA· 241-NETWORK CONTRACT OFFICE 01 (36C241)· 6505 · DRUGS AND BIOLOGICALS· FY2023· $1,043,813 net obligations· UEI YLYKVRPCTCR3· MA

Description

PYLARIFY & NEURACEQ BUY

First action · last action
2023-01-12 · 2024-01-22
Transactions
3
First transaction's obligation
$385,611
Base + all options value (sum of deltas)
$1,043,813
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79719D0170
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1,043,813$0Base award · 2023-01-12 · this action $385,611 · running total $385,611Modification P00001 · 2023-07-14 · this action $252,610 · running total $638,221Modification P00002 · 2024-01-22 · this action $405,592 · running total $1,043,813
  • Base2023-01-12+$385,611= $385,611
  • Mod P000012023-07-14+$252,610= $638,221
  • Mod P000022024-01-22+$405,592= $1,043,813
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2023-01-12+$385,611$385,611PYLARIFY & NEURACEQ BUY
Mod P00001· FUNDING ONLY ACTION2023-07-14+$252,610$638,221PYLARIFY & NEURACEQ BUY
Mod P00002· EXERCISE AN OPTION2024-01-22+$405,592$1,043,813PYLARIFY & NEURACEQ BUY

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI YLYKVRPCTCR3)

AwardOffice · PSC / listingNet obligationsFY
36C24626N0890246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$1,212,530FY2026
36C24626A0027246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26226F0313262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS$180,436FY2026
36C25026N0655250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$721,744FY2026
36C26026F0298260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$469,134FY2026
36C25026N0531250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS$559,352FY2026

Other recipients under 6505 from 241-NETWORK CONTRACT OFFICE 01 (36C241) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C24126P0328CARDINAL HEALTH 414, LLC241-NETWORK CONTRACT OFFICE 01 (36C241)$999,797FY2026
36C24126F0121MCKESSON CORPORATION241-NETWORK CONTRACT OFFICE 01 (36C241)$16,333FY2026
36C24126N0603AMERICAN NATIONAL RED CROSS, THE241-NETWORK CONTRACT OFFICE 01 (36C241)$1,998,719FY2026
36C24126F0112VANTIVE US HEALTHCARE LLC241-NETWORK CONTRACT OFFICE 01 (36C241)$545,567FY2026
36C24126F0109BOSTON SCIENTIFIC CORP241-NETWORK CONTRACT OFFICE 01 (36C241)$304,950FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24123F0104_3600_36F79719D0170_3600 · retrieved 2026-09-26.